Conferences
SCS AUA 2024: Financial Toxicity in Testicular Cancer Treatment, Validated Questionnaire Correlated Software Cost Modeling
November 2, 2024
SCS AUA 2024: Does the Use of Continuous Bladder Irrigation After TURBT Increase the Risk of Complications?
November 2, 2024
SCS AUA 2024: Should Veterans be Classified as High Risk for Prostate Cancer Screening: A Review of the Current Literature
November 1, 2024
SCS AUA 2024: Can the PSMA PET SUVmax Predict High Risk Pathology and High Risk Disease? A Single Center Prospective Disease
November 1, 2024
SCS AUA 2024: Elucidating the Response Rates to Additional BCG: Implications for Clinical Trial Design
November 1, 2024
SCS AUA 2024: Real-World Treatments Following BCG Induction in Patients with NMIBC: A Contemporary US Claims Analysis
November 1, 2024
SCS AUA 2024: Urothelial Carcinoma of the Prostate and Intravesical Therapy: A Cautionary Tale
November 1, 2024
SCS AUA 2024: Nephron Sparing Surgery for Localized Renal Masses
November 1, 2024
SCS AUA 2024: Efficacy of Intravesical Nadofaragene Firadenovec-VNCG for Patients with BCG-Unresponsive NMIBC: 36-Month Follow-Up from a Phase 3 Trial
November 1, 2024
SCS AUA 2024: Case Discussion: Management of Localized Renal Masses in Younger Patients and Patients with Heritable Kidney Cancer Syndromes
November 1, 2024